Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Biochemical Pharmacology|August 17, 2011
Relevance of both type-1 and type-2 corticotropin releasing factor receptors in stress-induced relapse to cocaine seeking behaviourKatia GyslingBrain Research. Brain Research Reviews|December 2, 2004
Role of noradrenergic projections to the bed nucleus of the stria terminalis in the regulation of the hypothalamic-pituitary-adrenal axisMaría Inés Forray, Katia GyslingJournal of Neuroscience Research|August 31, 2006
Desipramine prevents the sustained increase in corticotropin-releasing hormone-like immunoreactivity induced by repeated immobilization stress in the rat central extended amygdalaMarcos Santibañez, Katia Gysling, María Inés ForrayJournal of Neuroscience Research|May 28, 2005
Acute morphine administration increases extracellular DA levels in the rat lateral septum by decreasing the GABAergic inhibitory tone in the ventral tegmental areaRamón Sotomayor, María Inés Forray, Katia GyslingThe European Journal of Neuroscience|October 28, 2015
Corticotropin-releasing factor type-2 receptor and corticotropin-releasing factor-binding protein coexist in rat ventral tegmental area nerve terminals originated in the lateral hypothalamic areaPaula G Slater, Veronica Noches, Katia GyslingJournal of Neuroscience Research|June 3, 2005
Adrenalectomy decreases corticotropin-releasing hormone gene expression and increases noradrenaline and dopamine extracellular levels in the rat lateral bed nucleus of the stria terminalisMarcos Santibañez, Katia Gysling, María Inés ForrayNeuropharmacology|October 1, 2017
Lateral septum stimulation disinhibits dopaminergic neurons in the antero-ventral region of the ventral tegmental area: Role of GABA-A alpha 1 receptorsIgnacio Vega-Quiroga, Hector E Yarur, Katia GyslingSynapse (New York, N.Y.)|June 15, 2007
Increased locomotor response to amphetamine induced by the repeated administration of the selective kappa-opioid receptor agonist U-69593José Antonio Fuentealba, Katia Gysling, María Estela AndrésSynapse (New York, N.Y.)|October 13, 2010
Repeated treatment with the κ-opioid agonist U-69593 increases K+-stimulated dopamine release in the rat medial prefrontal cortexJosé Antonio Fuentealba, Katia Gysling, María Estela AndrésMolecular Pharmacology|September 11, 2016
Corticotropin-Releasing Factor Receptors and Their Interacting Proteins: Functional ConsequencesPaula G Slater, Hector E Yarur, Katia GyslingPageof 6